|
資訊服務
重要交易動向：癌（2011年）
Essential Deal Trends: Oncology 2011
|
重要交易動向：癌（2011年） 是由出版商PharmaVentures Ltd在Issues / Year: 12所出版的。
這份英文資訊服務包含60 Pages 價格從美金2395起跳。
本報告書為癌市場之合併、收購、認證等重要交易動向之整理、2000年以降成績與將來的預測，概述如下。
第1章 市場
第2章 交易動向
- 癌相關交易件數：2000∼2010年
- 癌相關交易總額
- 1997年以降各金額交易Top 15
- 摘要
第3章 交易種類
- 導論
- 戰略的交易
- 產品交易（包含認證契約）
- 合併・收購
- 行銷交易
- 提携・研究開發交易件數
- 各開發階段
- 各交易金額
- 案例研究
- 財務交易
- 製造以及其他交易
- 分析
第4章 各產品交易
- 生物製劑・小分子
- 診斷藥
- 疫苗
- 各產品類別交易分析
第5章 將來動向
第6章 總綱
附錄
Abstract
|
|
PharmaDeals® Essential Deal Trends is an exciting new deal trend analysis
resource from PharmaVentures' expert analysts. It provides crucial facts,
figures and analysis for business decision support, helping to answer
questions such as:
- ‘Can I benchmark my deals against others?’,
- ‘Are we getting the best value for our asset?’, or simply,
- ‘what are the characteristics of the deal making landscape within
our therapeutic space?’.
|
Essential Deal Trends publishes a new report based on key therapeutic areas
every month, such as Oncology, Diseases of the Cardiovascular System,
Vaccines, or Diseases of the Central Nervous System. For those fast-moving
areas, such as Oncology, we update the report every 6 months, to ensure you
have the latest trends at your instant disposal. Whether you're interested in
Mergers and Acquisitions, Licensing deals, or more exotic deal structures,
Essential Deal Trends offers expert analysis from Senior Consultants and
Advisors at PharmaVentures.
By segmenting deals by deal type, by phase of development, and by product
type, Essential Deal Trends is a must-have resource for everyone involved in
deal-making.
Features Include:
- Case studies classified as ‘Super Deals’,
‘Trend-Busters’, and ‘In-line Deals’
- We look at deals that are on trend, buck the trend or even represent a
potential paradigm shift; in each case, embedded Case Studies relate the
abstract numbers back to specific examples.
- Wealth of Tables and Figures ‘ready for use’
- At the heart of Essential Deal Trends lies the facts and figures that
underpin any analysis. Use the tables and figures directly in your
presentations and reports.
- PharmaDeals iReport offers much more
- Fully searchable and interactive online format. Great search facility,
language help (in 9 languages, including Japanese, French, German and
Spanish), and easy to browse and get the text, tables and figures you need -
quickly.
- Our systematic approach help you organize your information for further
meta-analysis
- All reports in the series have a consistent structure, which means that
you can easily navigate between reports, extracting information across
multiple reports and making comparison. For instance, if you are interested
in conducting meta analysis on graphs of deals numbers by phase of
development across multiple therapeutic areas, then simply use the Cut and
Paste feature to create your own report.
- Fully exportable in different formats
- All text, figures and tables are exportable into MS PowerPoint, MS Word
and PDF, allowing you to manipulate the data to suit your own analytical or
forecasting needs.
- Deal Linking
- Essential Deal Trends is underpinned by PharmaDeals' unique, proprietary
database which provides timely, actionable, market intelligence for
analysts, business developers and company executives in the life-sciences
sector. Drawing on extensive data covering over 41,000 deals, Essential Deal
Trends gives in-depth, detailed insight into a range of different deal types
across therapeutic areas. Link quickly from the reports to the full deal
records (requires a PharmaDeals Agreements subscription).
Table of Contents
Preface
How to use this report
1. The Market
- Market Drivers
- Market Size
- Key Players
- Products in Development
2. Trends in Dealmaking
- Total Number of Oncology Deals 2000-2010
- Total Value of Oncology Deals
- Top 15 deals by value since 1997
- Deal Trend Summary
3. Deal Types
- Strategic Deals
- Total Number of Strategic Deals
- Deals by Stage of Development
- Deals by Total Deals Value
- Case Studies
- Product Deals (including Licensing deals)
- Strategic Deals by Type
- Deals by Stage of Development
- Deals by Total Deals Value
- Case Studies
- Mergers & Acquisition Deals
- Total number of M&A deals
- Deals by Stage of Development
- Deals by Total Deals Value
- Case Studies
- Marketing Deals
- Total number of Collaborative and R&D Deals
- Deals by Stage of Development
- Deals by Deals Value
- Case Studies
- Financial Deals
- Total number of Finance-based deals
- Deals by Stage of Development
- Deals by Deals Value
- Case Studies
- Manufacturing and Other Deals
- Total number of Other Deals
- Deals by Stage of Development
- Deals by Deals Value
- Case Studies
- Analysis
- Analysis of Deal Types
- Expectations over the next 5 years
4. Deals by Product Type
- Biologicals and small molecules
- Total Number of Deals over last 10 years
- Case Studies
- Diagnostics
- Total Number of Deals over last 10 years
- Case studies
- Vaccines
- Total Number of Deals over last 10 years
- Case studies
- Analysis of Deals by Product Type
5. Future Trends
6. Executive Summary
Appendices
- Appendix 1. Oncology Deals Data for Q3 and Q4 of 2010, and Q1 and Q2 of
2011
- Appendix 2. Industry Views and Opinion on Oncology
|
